Background: The paradox that smokers have better clinical outcomes in cardiovascular diseases remains controversial. No literature exists studying impact of smoking on outcomes following transcatheter aortic valve replacement (TAVR).
Methods: We performed an electronic search of the 2011-2012 National Inpatient Sample (NIS) database to identify all TAVR hospitalizations. Outcomes were measured comparing smokers to non-smokers.
Results: A total of 8,345 TAVR hospitalizations were identified with 24% being smokers. Compared to non-smokers, smokers were younger (80.4±8.8 vs. 81.4±9.2 years, P
Conclusions: Despite having a higher cardiovascular disease burden, smokers had better outcomes compared to non-smokers. Therefore the smoker's paradox is applicable in the TAVR cohort.
Published In/Presented At
Agarwal, M., Agrawal, S., Garg, L., Reed, G. L., Khouzam, R. N., & Ibebuogu, U. N. (2018). Impact of smoking in patients undergoing transcatheter aortic valve replacement. Annals Of Translational Medicine, 6(1), 2. doi:10.21037/atm.2017.11.32
Cardiology | Medical Sciences | Medicine and Health Sciences
Department of Medicine, Cardiology Division, Department of Medicine Fellows and Residents